Alan Haruo Bryce, Maelys Touya, David Nimke, Christopher Young, Samantha Shao, Nigel Rozario, Pinal Kamdar, Jasmina I. Ivanova, Irene Varghese, Joerg Herrmann. "Cardiovascular (CV) event risk in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA) or abiraterone acetate (AA) in the United States (US).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5041